Quantum量子訊息有限公司
← 最新全球產業報告

IVD Raw Materials Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-03-26 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 34,281.6 Mn
2033 年預估規模
USD 50,790.6 Mn
年複合成長率 CAGR
5.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-03-26頁數 152報告編號 CMI5234

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
IVD Raw Materials Market, By Product (Antibodies & Antigens, Enzymes, Proteins, Biological Buffers, Others), By Technology (Clinical Chemistry, Immunochemistry, Molecular diagnostics, Others), By End-User (Pharma, Biotech & MedTech Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits. Market Dynamics The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period. In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes. Key features of the study • This report provides in-depth analysis of the global IVD raw materials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year. • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players. • It profiles key players in the global IVD raw materials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies. • Key companies covered as a part of this study include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, Thermo Fisher Scientific, among others. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics. • The global IVD raw materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IVD raw materials market. Market Segmentation • Global IVD Raw Materials Market, By Product o Antibodies & Antigens o Enzymes o Proteins o Biological Buffers o Others • Global IVD Raw Materials Market, By Technology o Clinical Chemistry o Immunochemistry o Molecular diagnostics o Others • Global IVD Raw Materials Market, By End-User o Pharma, Biotech & MedTech Companies o Diagnostic Laboratories o Others • Global IVD Raw Materials Market, By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Global IVD Raw Materials Market: Key Players o Aalto Bio Reagents o Fapon Biotech o Fujirebio o Merck KgaA o Hoffmann-La Roche o Thermo Fisher Scientific
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product  Market Snapshot, By Technology  Market Snapshot, By End User  Market Snapshot, By Geography o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product launch/Approvals o PEST Analysis o PORTER’s Analysis o Merger and Acquisition Scenario 4. Global IVD Raw Materials Market, By Product, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Antibodies & Antigens  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Enzymes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Proteins  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Biological Buffers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 5. Global IVD Raw Materials Market, Technology, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Clinical Chemistry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Immunochemistry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Molecular diagnostics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 6. Global IVD Raw Materials Market, By End User, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Pharma, Biotech & MedTech Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 7. Global IVD Raw Materials Market, By Geography, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn) o U.S. o Canada o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Middle East and Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn) o GCC o Israel o Rest of Middle East o South Africa o Central Africa o North Africa o Rest of World 8. Competitive Landscape o Aalto Bio Reagents  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Fapon Biotech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Fujirebio  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck KgaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hoffmann-La Roche  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Analyst Views 9. Section o Research Methodology o About us

提及公司

Aalto Bio ReagentsFapon BiotechFujirebioMerck KgaAHoffmann-La RocheThermo Fisher Scientific

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們